Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902219-21-000231
Filing Date
2021-02-04
Accepted
2021-02-04 11:19:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G/A 35505
  Complete submission text file 0000902219-21-000231.txt   37347
Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Subject) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91200 | Film No.: 21589672
SIC: 2834 Pharmaceutical Preparations